1.40
Schlusskurs vom Vortag:
$2.33
Offen:
$1.89
24-Stunden-Volumen:
9.51M
Relative Volume:
9.34
Marktkapitalisierung:
$228.93M
Einnahmen:
$624.29M
Nettoeinkommen (Verlust:
$6.86M
KGV:
19.23
EPS:
0.0728
Netto-Cashflow:
$-74.35M
1W Leistung:
-39.39%
1M Leistung:
-45.53%
6M Leistung:
-65.00%
1J Leistung:
-54.47%
Docgo Inc Stock (DCGO) Company Profile
Firmenname
Docgo Inc
Sektor
Branche
Telefon
(844) 443-6246
Adresse
685 THIRD AVENUE, NEW YORK
Vergleichen Sie DCGO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DCGO
Docgo Inc
|
1.40 | 228.93M | 624.29M | 6.86M | -74.35M | 0.0728 |
![]()
HCA
Hca Healthcare Inc
|
353.70 | 83.71B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
28.39 | 15.02B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
THC
Tenet Healthcare Corp
|
148.83 | 13.75B | 20.97B | 3.13B | 2.39B | 31.21 |
![]()
EHC
Encompass Health Corp
|
116.41 | 11.76B | 5.22B | 422.40M | 269.50M | 4.14 |
![]()
UHS
Universal Health Services Inc
|
181.78 | 11.65B | 15.42B | 1.03B | 956.84M | 15.02 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
2025-02-28 | Herabstufung | Deutsche Bank | Buy → Hold |
2023-08-18 | Eingeleitet | BTIG Research | Buy |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
2022-01-19 | Eingeleitet | Stifel | Buy |
2021-12-21 | Eingeleitet | Canaccord Genuity | Buy |
2021-12-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Docgo Inc Aktie (DCGO) Neueste Nachrichten
DocGo First Quarter 2025 Earnings: Misses Expectations - Yahoo
DocGo Inc. (NASDAQ:DCGO) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG cuts DocGo stock rating following weak Q1 results By Investing.com - Investing.com South Africa
DocGo, Inc. Earnings Call: Growth Amid Challenges - TipRanks
DocGo (DCGO): Analyst Maintains Rating, Lowers Price Target | DCGO Stock News - GuruFocus
DocGo (DCGO) Price Target Reduced by Analyst Following Earnings Miss | DCGO Stock News - GuruFocus
BTIG cuts DocGo stock rating following weak Q1 results - Investing.com
DocGo downgraded to Neutral from Buy at BTIG - TipRanks
DocGo (DCGO) Faces Downgrade Amid Revenue Concerns | DCGO Stock News - GuruFocus
DocGo Inc (DCGO) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: DocGo Q1 2025 results disappoint, stock plunges - Investing.com
DocGo Inc. Reports Q1 2025 Earnings Amid Strategic Shift - TipRanks
DocGo Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: DocGo Q1 2025 results disappoint, stock plunges By Investing.com - Investing.com UK
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
DocGo Announces First Quarter 2025 Results - Business Wire
What To Expect From DocGo Inc (DCGO) Q1 2025 Earnings - GuruFocus
DocGo Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
DocGo Inc. (DCGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc.DCGO - Business Wire
Press Release Distribution & PR Platform - ACCESS Newswire
How the (DCGO) price action is used to our Advantage - news.stocktradersdaily.com
DocGo to Announce First Quarter Results on Thursday, May 8, 2025 - 01net
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc.DCGO - The Malaysian Reserve
Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is It Too Late To Consider Buying DocGo Inc. (NASDAQ:DCGO)? - simplywall.st
DocGo stock touches 52-week low at $2.31 amid market shifts - Investing.com Australia
DocGo stock touches 52-week low at $2.31 amid market shifts By Investing.com - Investing.com South Africa
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm - GlobeNewswire
Expert Outlook: DocGo Through The Eyes Of 4 Analysts - Benzinga
DocGo Stock Touches 52-Week Low at $2.4 Amid Market Challenges - Investing.com Australia
DocGo Stock Touches 52-Week Low at $2.4 Amid Market Challenges By Investing.com - Investing.com South Africa
DocGo at Needham Conference: Strategic Shift to Payer Business By Investing.com - Investing.com Canada
DocGo at Needham Conference: Strategic Shift to Payer Business - Investing.com
Long Term Trading Analysis for (DCGO) - news.stocktradersdaily.com
DocGo Inc. (NASDAQ:DCGO) is definitely on the radar of institutional investors who own 50% of the company - Yahoo
DocGo Can't Nix Investor Suit Over 'Indisputably False' Claims - Law360
DocGo Earns Great Place To Work Certification™ For the Third Time in a Row - 01net
DocGo Outperforms 31% of US Companies in Workplace ExcellenceWins Triple Certification - Stock Titan
DocGo stock touches 52-week low at $2.63 amid market shifts By Investing.com - Investing.com South Africa
DocGo stock touches 52-week low at $2.63 amid market shifts - Investing.com India
Finanzdaten der Docgo Inc-Aktie (DCGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):